Array Biopharma Wins Two Important Deals In Six Months, But Wall Street Shrugs
This article was originally published in The Pink Sheet Daily
Executive Summary
To management's frustration, the biotech's deals with Novartis and Amgen haven't helped its market cap, one more sign that validating deals with Big Pharma don't move investors.